Agilent Technologies (A)
NYSE:A
Want to see A full AI Analyst Report?
A Stock Chart & Stats
$121.87
-$0.52(-0.38%)
At close: 4:00 PM EST
$121.87
-$0.52(-0.38%)
Day’s Range― - ―
52-Week Range$108.35 - $160.27
Previous CloseN/A
Volume231.77K
Average Volume (3M)2.34M
Market Cap
$38.30B
Enterprise Value$39.85B
Total Cash (Recent Filing)$1.81B
Total Debt (Recent Filing)$3.35B
Price to Earnings (P/E)27.1
Beta0.98
Next Earnings
Aug 18, 2026EPS Estimate
1.49Next Dividend Ex-DateN/A
Dividend Yield0.72%
Share Statistics
EPS (TTM)4.99
Shares Outstanding282,602,330
10 Day Avg. Volume2,750,876
30 Day Avg. Volume2,339,149
Financial Highlights & Ratios
PEG Ratio9.41
Price to Book (P/B)6.14
Price to Sales (P/S)5.96
P/FCF Ratio35.95
Enterprise Value/Market Cap1.04
Enterprise Value/Revenue5.51
Enterprise Value/Gross Profit10.40
Enterprise Value/Ebitda21.41
Forecast
1Y Price Target
$157.62Price Target Upside29.33% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering13
EPS Forecast (FY)6.04
Revenue Forecast (FY)$7.43B
Bulls Say, Bears Say
Bulls Say
Recurring Consumables & ServicesAgilent’s mix of capital equipment plus recurring consumables, reagents, software and services builds durable, high-frequency revenue from an expanding installed base. This recurring stream improves revenue visibility, supports gross-margin stability and cushions cyclicality tied to one-time instrument sales over the next 2–6 months.
Margin Expansion And Pricing PowerConsistent margin expansion—driven by realized pricing (Ignite ~200 bps), manufacturing overhead reductions and product mix—signals structural pricing power and operational leverage. If management sustains pricing and productivity, margins should continue to support durable profitability despite macro pressures.
Healthy Free Cash Flow And Balance-sheet FlexibilityRobust FCF generation and improving leverage provide long-term financial flexibility to fund R&D, targeted M&A, dividends and buybacks while maintaining capex. Strong cash conversion supports strategic investments and cushions the business against short-term demand swings or higher funding costs.
Bears Say
China End-market ExposureMeaningful exposure to China leaves growth vulnerable to funding timing, policy shifts and local demand cycles. Prolonged weakness or delayed stimulus can materially depress instrument orders and consumables consumption, creating persistent headwinds to organic growth and near-term guidance conversion.
Margin Pressure Vs. Prior YearsAlthough recent quarters showed margin improvement, underlying gross-margin pressure versus historical peaks indicates structural cost or mix challenges. If pricing and productivity gains prove temporary, margins and long-term earnings leverage could be constrained, reducing sustainable profitability.
Weaker Operating Cash ConversionReduced cash conversion implies working-capital timing or collection stresses, lowering the quality of reported earnings. Persistent weakness here could limit free-cash-flow predictability, constrain reinvestment or raise refinancing risk if macro conditions tighten, harming long-term financial flexibility.
Agilent News
A FAQ
What was Agilent Technologies’s price range in the past 12 months?
Agilent Technologies lowest stock price was $108.35 and its highest was $160.27 in the past 12 months.
What is Agilent Technologies’s market cap?
Agilent Technologies’s market cap is $38.30B.
When is Agilent Technologies’s upcoming earnings report date?
Agilent Technologies’s upcoming earnings report date is Aug 18, 2026 which is in 79 days.
How were Agilent Technologies’s earnings last quarter?
Agilent Technologies released its earnings results on May 27, 2026. The company reported $1.49 earnings per share for the quarter, beating the consensus estimate of $1.408 by $0.082.
Is Agilent Technologies overvalued?
According to Wall Street analysts Agilent Technologies’s price is currently Undervalued.
Does Agilent Technologies pay dividends?
Agilent Technologies pays a Quarterly dividend of $0.255 which represents an annual dividend yield of 0.72%. See more information on Agilent Technologies dividends here
What is Agilent Technologies’s EPS estimate?
Agilent Technologies’s EPS estimate is 1.49.
How many shares outstanding does Agilent Technologies have?
Agilent Technologies has 282,602,330 shares outstanding.
What happened to Agilent Technologies’s price movement after its last earnings report?
Agilent Technologies reported an EPS of $1.49 in its last earnings report, beating expectations of $1.408. Following the earnings report the stock price went up 16.868%.
Which hedge fund is a major shareholder of Agilent Technologies?
Currently, no hedge funds are holding shares in A
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Agilent Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$157.62 (29.33% Upside)
$157.62 (29.33% Upside)
Blogger Sentiment
Bullish
A Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 4.1M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 3.1%
Last 30 Days ▲ 3.6%
Last 30 Days ▲ 3.6%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 4%
Bearish news 4%
Technicals
SMA
Negative
20 days / 200 days
Momentum
20.62%
12-Months-Change
Fundamentals
Return on Equity
20.84%
Trailing 12-Months
Asset Growth
7.46%
Trailing 12-Months
Company Description
Agilent Technologies
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
A Company Deck
A Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a strong operational and financial performance: revenue, margins, and EPS all beat expectations, management raised full‑year guidance, and multiple indicators (instrument orders, segment outperformance, pricing, supply chain resilience and product innovation) point to durable momentum. Near-term challenges include China softness, food and academia/government weakness, and inflationary/geopolitical cost pressures that add uncertainty. On balance the positive operational wins and upgraded guidance outweigh the cited headwinds.View all A earnings summariesA Revenue Breakdown
39.23% Life Sciences and Diagnostics Markets
41.85% Agilent CrossLab
18.91% Applied Markets
A Stock 12 Month Forecast
Average Price Target
$157.62
▲(29.33% Upside)
Technical Analysis
Ownership Overview
0.19% Insiders
26.94% Mutual Funds
20.09% Other Institutional Investors
26.15% Public Companies and Individual Investors